Validation of a Hypertension Education Program
Not Applicable
- Conditions
- Arterial Hypertension
- Registration Number
- NCT02676414
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The primary purpose of this study is to assess the effect of participating in the interactive hypertension education program of the German Hypertension League (DHL©) "My blood pressure - OK!" on office systolic blood pressure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 134
Inclusion Criteria
- > 21 years of age
- Primary arterial hypertension
- Office blood pressure between 140/90 mmHg and 160/100 mmHg
Exclusion Criteria
- Participation in another clinical study
- Unstable clinical condition
- Secondary arterial hypertension
- Dementia
- Major disability (modified Rankin-Scale > 4)
- Severe chronic kidney disease (serum creatinine > 2.0 mg/dL or estimated glomerular filtration rate < 40 ml/min/1.73m2)
- Liver disease including history of hepatic encephalopathy, esophageal varices or portacaval shunt
- History of gastrointestinal operation or disease with a potential influence on drug absorption
- Allergy or other contraindications against drugs given during the study
- History of non-compliance
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Office systolic blood pressure (mmHg) 6 months
- Secondary Outcome Measures
Name Time Method 24-hour ambulatory blood pressure monitoring (mmHg) 6 months Alcohol consumption (drinks per week) 6 months Knowledge regarding arterial hypertension based on the DHL© Questionnaire 6 months Self-measured systolic and diastolic blood pressure (mmHg) 6 months Body Mass Index (kg per m2) 6 months Physical activity (hours per week) 6 months Quality of life based on the Quality of Life Questionnaire "The Short Form 36 Health Survey" 6 months Office diastolic blood pressure (mmHg) 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are influenced by the DHL© hypertension education program in NCT02676414 conducted by Charité University?
How does the DHL© interactive education program in NCT02676414 compare to standard pharmacological therapies for reducing office systolic blood pressure?
Which biomarkers predict response to the DHL© program in NCT02676414 for primary arterial hypertension patients?
What adverse events are associated with the DHL© program in NCT02676414 and their management strategies?
How does the DHL© program in NCT02676414 integrate with lifestyle changes and antihypertensive medications for blood pressure control?
Trial Locations
- Locations (1)
Herz- und Diabeteszentrum Ruhr-Universität Bochum
🇩🇪Bad Oeynhausen, Nordrhein-Westfalen, Germany
Herz- und Diabeteszentrum Ruhr-Universität Bochum🇩🇪Bad Oeynhausen, Nordrhein-Westfalen, GermanySiegfried Eckert, MDContact